Scott Requadt - Jul 29, 2022 Form 4 Insider Report for Talaris Therapeutics, Inc. (TALS)

Role
Chief Executive Officer, Director
Signature
/s/ Mary Kay Fenton, attorney-in-fact
Stock symbol
TALS
Transactions as of
Jul 29, 2022
Transactions value $
$167,374
Form type
4
Date filed
8/2/2022, 05:02 PM
Previous filing
Jul 28, 2022
Next filing
Sep 13, 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TALS Common Stock Purchase $167K +39.4K +8.39% $4.25 509K Jul 29, 2022 Direct
holding TALS Common Stock 450K Jul 29, 2022 See Footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares are held by Requadt Family Limited Partnership. The Reporting Person has voting and dispositive power over the shares beneficially owned by Requadt Family Limited Partnership.